Safety and Efficacy of JMKX000189 for Chemotherapy-Induced Peripheral Neuropathy

Phase 1 Not yet recruiting 18 enrolled Shanghai Jeyou Pharmaceutical Co., Ltd.

RandomizedParallel-groupDouble-blindTreatment

Summary

This Phase Ib clinical trial aims to evaluate the safety, tolerability, and preliminary efficacy of JMKX000189 tablets in participants with chemotherapy-induced peripheral neuropathy (CIPN).

Timeline

Start: 2026-05-10
Primary completion: 2027-06-20
Completion: 2027-06-20

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	JMKX000189	Unknown	—	Oral

Safety and Efficacy of JMKX000189 for Chemotherapy-Induced Peripheral Neuropathy

Summary

Timeline

Drugs

Indications